Author:
Editor(s):
Updated:
ULY CLINIC
ULY CLINIC
9 Septemba 2025, 04:36:37
Dystonia
Dystonia is a movement disorder characterized by slow, involuntary, and often twisting movements involving large muscle groups, including the limbs, trunk, and neck. It may present as intermittent episodes or continuous, sometimes painful contractions. Dystonia can result in abnormal postures, occasionally leading to permanent contractures. Common forms include focal dystonia (affecting a single body region, e.g., spasmodic torticollis), segmental, or generalized dystonia. Etiologies include hereditary, idiopathic, extrapyramidal disorders, or drug-induced causes.
Pathophysiology
Dystonia arises from dysfunction of the basal ganglia and associated extrapyramidal motor pathways. Abnormal signaling in these circuits leads to excessive co-contraction of agonist and antagonist muscles. Secondary dystonia can result from:
Neurodegenerative diseases (e.g., Parkinson’s disease, Huntington’s disease)
Drug-induced changes (e.g., phenothiazines, metoclopramide)
Metabolic disorders (e.g., Wilson’s disease)
Structural lesions affecting basal ganglia or thalamus
The disorder is aggravated by voluntary movements, walking, or emotional stress and usually improves with sleep.
Signs and Symptoms
Slow, involuntary twisting or writhing movements
Intermittent or continuous muscular contractions
Abnormal postures: foot inversion, leg hyperextension, arm pronation, trunk arching, neck rotation (spasmodic torticollis)
Painful contractions in severe cases
Associated features may include dysarthria, dysphagia, emotional lability, and in chronic cases, permanent contractures
Clinical Assessment
History
Determine onset, duration, and triggers (e.g., emotional stress, walking)
Family history of dystonia or movement disorders
Drug history (especially antipsychotics, phenothiazines, metoclopramide)
Associated neurological symptoms (tremor, rigidity, chorea, weakness)
Impact on daily activities and sleep
Presence of comorbidities (neurodegenerative disorders, metabolic conditions)
Physical Examination
Observe gait and posture
Assess voluntary motor function:
Gross motor: heel-to-knee-to-toe test
Fine motor: finger-to-thumb opposition
Coordination: finger-to-nose test
Assess muscle tone, strength, and presence of abnormal contractions
Differentiate from other movement disorders:
Chorea: rapid, jerky, unpredictable
Athetosis: slow, continuous, writhing (hands/extremities)
Look for dystonic postures of neck, trunk, or limbs
Neurological examination for additional deficits
Investigation
Laboratory tests: serum ceruloplasmin, copper levels (Wilson’s disease), metabolic panel
Neuroimaging: MRI or CT of brain to identify basal ganglia lesions or structural abnormalities
Electromyography (EMG): characterizes abnormal muscle contractions
Genetic testing for hereditary forms of dystonia (DYT1 mutation, etc.)
Drug review to assess for drug-induced dystonia
Medical causes of dystonia
Cause | Onset/Pattern | Distinguishing Features |
Alzheimer’s disease | Gradual, late-stage | Slowly progressive dementia, decreased attention span, amnesia, agitation, inability to perform ADLs, dysarthria, emotional lability; dystonia is a late sign. |
Dystonia musculorum deformans | Childhood onset, progressive | Generalized dystonia worsening with age; initial foot inversion, growth retardation, scoliosis; later twisted postures, limb contractures, dysarthria. |
Hallervorden-Spatz disease | Childhood/adolescent onset, progressive | Degenerative disorder with dystonic trunk movements, choreoathetosis, ataxia, myoclonus, rigidity, progressive intellectual decline, dysarthria; often associated with basal ganglia iron accumulation. |
Huntington’s disease | Adult onset, progressive | Preterminal stage marked by dystonia; choreoathetosis, dysarthria, dysphagia, facial grimacing, wide-based prancing gait, dementia, emotional lability. |
Parkinson’s disease | Gradual, progressive | Dystonic spasms common; other features: uniform or jerky rigidity, pill-rolling tremor, bradykinesia, dysarthria, dysphagia, drooling, masklike facies, monotone voice, stooped posture, propulsive gait. |
Wilson’s disease | Childhood/adolescent onset, progressive | Dystonia and chorea of arms/legs, hoarseness, bradykinesia, behavior changes, dysphagia, drooling, dysarthria, tremors, Kayser-Fleischer rings. |
Drugs (phenothiazines, antipsychotics, metoclopramide) | Acute/subacute | Drug-induced dystonia; piperazine phenothiazines (acetophenazine, carphenazine) most common; facial dystonia frequent; may occur after starting or changing dose; reversible with drug adjustment or anticholinergics. |
Differential Diagnosis
Chorea (rapid, jerky movements)
Athetosis (continuous, writhing movements)
Spasticity due to cerebral palsy or stroke
Tics (sudden, repetitive movements)
Parkinsonism
Myoclonus
Pediatric Considerations
Onset usually occurs after children can walk, rarely before age 10
Common pediatric causes:
Dystonia musculorum deformans
Fahr’s syndrome
Athetoid cerebral palsy
Residual effects of neonatal anoxia
Gait abnormalities and progressive postural changes are often early indicators
Special Clinical Considerations
Encourage adequate sleep and minimize emotional stress
Avoid range-of-motion exercises that exacerbate dystonia
Protect the patient from injury (padded bed rails, safe environment)
Monitor for secondary complications: contractures, joint deformities, aspiration risk
Patient education & Counseling
Explain the nature of dystonia and its chronic course
Educate about treatment options: medications (anticholinergics, benzodiazepines, botulinum toxin injections), deep brain stimulation in selected cases
Emphasize stress management, sleep hygiene, and supportive therapies
Encourage participation in support groups and mental health services as needed
References
Andrews C, Aviles-Olmos I, Hariz M, Foltynie T. Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes. J Neurol Neurosurg Psychiatry. 2010;81:1383–1389.
Brighina F, Romano M, Giglia G, Saia V, Puma A, Giglia F, et al. Effects of cerebellar TMS on motor cortex of patients with focal dystonia: A preliminary report. Exp Brain Res. 2009;192:651–656.
Fahn S, Jankovic J, Hallett M. Principles and Practice of Movement Disorders. 2nd ed. Philadelphia: Elsevier; 2011.
Albanese A, Bhatia K, Bressman SB, DeLong MR, Fahn S, Fung VS, et al. Phenomenology and classification of dystonia: A consensus update. Mov Disord. 2013;28:863–873.
Jankovic J. Treatment of dystonia. Lancet Neurol. 2006;5:864–872.
